Moleculin Biotech (MBRX) Tops Q1 EPS by 209c

Moleculin Biotech (NASDAQ: MBRX) reported Q1 EPS of ($0.69), $2.09 better than the analyst estimate of ($2.78).

For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.

You May Also Be Interested In

• Oracle (ORCL) call put ratio 2.3 calls to 1 put with a focus on October calls into quarter results
• Dyne Therapeutics (DYN) PT Lowered to $37 at Raymond James
• Increasing unusual put volume: MNDY BILI HWM SHW NVS AEP GRAB AXTX STT CAMT XEL TRIP ROST BCRX SBLK